Log In
Print
BCIQ
Print
Print this Print this
 

Cardionovo, alferminogene tadenovec (Generx) (Ad5FGF4)

  Manage Alerts
Collapse Summary General Information
Company Taxus Cardium Pharmaceuticals Group Inc.
DescriptionAdenoviral vector carrying the fibroblast growth factor 4 (FGF4) gene
Molecular Target Fibroblast growth factor 4 (FGF4)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adenovirus

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$8.0M

$3.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today